Public perceptions of high-cost cancer drugs and the implications for reimbursement decisions
The South Korean public perceives the reimbursement of high-cost cancer drugs as both a human rights measure and a government responsibility. However, they support reimbursement only when they are confident that the drug is safe, effective, and cost-effective.
Authors
- Younghee Noh (ORCID: https://orcid.org/0000-0002-0046-4038)
- Kyung‐Bok Son (ORCID: https://orcid.org/0000-0002-6343-5808)
Institutions
- Hanyang University (KR)
Publication Details
- Journal
- Health Economics Review
- Published
- 2025-07-12
- DOI
- https://doi.org/10.1186/s13561-025-00659-y
- Primary Topic
- Economic and Financial Impacts of Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Research Foundation
- National Research Foundation of Korea